Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Structuring Financial Incentives to Increase Physical Activity

2 ottobre 2019 aggiornato da: Prof Ho Teck Hua, National University of Singapore

The purpose of this study is to evaluate the effectiveness of different structures of long term financial incentives on increasing physical activity performed by subjects, as measured by the number of steps walked per day.

Investigators are interested in studying whether physical activity increases during an intervention period (with incentives) and a post-intervention period (with no incentives).

Panoramica dello studio

Stato

Completato

Descrizione dettagliata

The proposed study is a field experiment. Adults within the ages of 25 and 60 years of age, and with a body mass index of 22 or higher will be eligible to participate.

The study will consist of (1) a two-week baseline period, (2) a 36-week intervention period, and (3) a 12-week follow-up period.

At the beginning of the study, subjects will be given a wearable fitness device and their daily step count will be monitored for two weeks; this is the baseline period. After the two-week baseline period, the subjects will be randomly assigned to one of the five different conditions (Control, Gain, Loss, Gain Streak, or Loss Streak) and will be given the goal to increase their baseline step counts by 2,500 steps.

=====

HYPOTHESES -- Investigators expect the following:

  1. Loss Aversion: Subjects in the Loss treatment will achieve the goal on a greater number of days than subjects in the Gain treatment.
  2. Streak: Subjects in the Gain treatment will achieve the goal on a greater number of days than subjects in the Gain Streak treatment.
  3. Loss Streak: Subjects in the Loss treatment will achieve the goal on a greater number of days than subjects in the Loss Streak treatment. Whether subjects in the Loss Streak treatment will perform better or worse than subjects in the other two treatments will be investigated.

CONTRIBUTION -- Prior research has not examined the effect of a long term financial incentive (36 weeks) on individual behavior in achieving a goal. In this study, the investigators also examine two additional financial incentive structures: Gain Streak and Loss Streak. If the hypotheses are correct, the results have important implications for designing financial incentives to encourage good behavior and to encourage good habit formation across domains.

Tipo di studio

Interventistico

Iscrizione (Effettivo)

620

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

      • Singapore, Singapore, 119077
        • National University of Singapore

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

Da 25 anni a 60 anni (Adulto)

Accetta volontari sani

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion Criteria:

  • Singapore citizens and permanent residents
  • Adults with BMI greater than 22
  • Ownership of a smartphone or tablet
  • Only one member per household can participate in the study

Exclusion Criteria:

  • Women who are pregnant or breast feeding, or who intend to become pregnant over next year
  • Subjects who are already participating in another physical activity program or study
  • Subjects who are unable to participate for a total of 1 year
  • Subjects who are unwilling to wear the fitness device
  • Subjects who already walk more than 10,000 steps a day (self-reported per-day-average over seven days)
  • Subjects who have any of the following health conditions:

    • high blood pressure
    • high cholesterol
    • heart attack
    • heart failure
    • stroke
    • chronic obstructive pulmonary disease
    • kidney disease
    • diabetes (type 2)

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Altro
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Doppio

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Nessun intervento: Control
Subjects in the Control treatment are not given any financial incentive to achieve the goal.
Sperimentale: Gain Treatment
Financial Incentive: Each subject in the Gain treatment will earn a certain amount of money for each day the goal is achieved. The money earned will be added to a virtual account that the subject has, and will be paid to the subject at the end of the intervention period.
Giving different structures of long term (36 weeks) financial incentives to increase physical activity
Sperimentale: Loss Treatment
Financial Incentive: Each subject in the Loss treatment will be given a certain amount of money in his/her virtual account at the beginning of every week. For each day that the subject does not achieve the goal, a small portion of that money will be deducted from the virtual account. The balance that is left in the virtual account will be paid to the subject at the end of the intervention period.
Giving different structures of long term (36 weeks) financial incentives to increase physical activity
Sperimentale: Gain Streak Treatment
Financial Incentive: Each subject in the Gain Streak treatment get an increasing amount of money added to his/her virtual account for every continuous day that they achieve the goal. The maximum cumulative amount per week is same as in the other treatment conditions. The payment is reset at the beginning of each week, or if the subject misses the goal on any day. The money in the virtual account will be paid to the subject at the end of the intervention period.
Giving different structures of long term (36 weeks) financial incentives to increase physical activity
Sperimentale: Loss Streak Treatment
Financial Incentive: Each subject in the Loss Streak treatment will be given a certain amount of money in his/her virtual account at the beginning of every week. An increasing amount of money will be deducted for each consecutive day the subject does not achieve the goal. The payment is reset at the beginning of each week, or when the subject achieves the goal (i.e., deductions are reset when the streak is broken). The balance that is left in the virtual account will be paid to the subject at the end of the intervention period.
Giving different structures of long term (36 weeks) financial incentives to increase physical activity

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Step count goal -- Intervention
Lasso di tempo: 36-week intervention period following the baseline period.
Proportion of participant-days on which the goal (baseline +2,500 steps) was achieved during the intervention period.
36-week intervention period following the baseline period.
Change in mean daily steps -- Intervention
Lasso di tempo: 36-week intervention period following the baseline period.
Change in mean daily steps during the intervention period.
36-week intervention period following the baseline period.

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Step count goal -- Post-intervention
Lasso di tempo: 12-week post-intervention period.
Proportion of participant-days on which the goal (baseline +2,500 steps) was achieved during the post-intervention period.
12-week post-intervention period.
Change in mean daily steps -- Post-intervention
Lasso di tempo: 12-week post-intervention period.
Change in mean daily steps during the post-intervention period.
12-week post-intervention period.
Sleep Pattern -- Intervention
Lasso di tempo: 36-week intervention period following the baseline period.
Changes in sleep pattern (deep sleep, hours of continuous sleep) during the intervention period.
36-week intervention period following the baseline period.
Sleep Pattern -- Post-intervention
Lasso di tempo: 12-week post-intervention period.
Changes in sleep pattern (deep sleep, hours of continuous sleep) during the post-intervention period.
12-week post-intervention period.
Weight (in kilograms) Loss -- Intervention
Lasso di tempo: 36-week intervention period following the baseline period.
Drop in weight from baseline to the end of the intervention period.
36-week intervention period following the baseline period.
Weight (in kilograms) Loss -- Post-intervention
Lasso di tempo: 48-week period following the baseline period.
Drop in weight from baseline to the end of the post-intervention period.
48-week period following the baseline period.
Change in Waist Measurement (in inches) -- Intervention
Lasso di tempo: 36-week intervention period following the baseline period
Change in waist measurements from baseline to the end of the intervention period.
36-week intervention period following the baseline period
Change in Waist Measurement (in inches) -- Post-intervention
Lasso di tempo: 48-week period following the baseline period.
Change in waist measurements from baseline to the end of the post-intervention period.
48-week period following the baseline period.

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Investigatori

  • Investigatore principale: Teck H Ho, PhD, National University of Singapore

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

9 ottobre 2017

Completamento primario (Effettivo)

17 gennaio 2019

Completamento dello studio (Effettivo)

30 gennaio 2019

Date di iscrizione allo studio

Primo inviato

26 settembre 2017

Primo inviato che soddisfa i criteri di controllo qualità

3 ottobre 2017

Primo Inserito (Effettivo)

9 ottobre 2017

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

4 ottobre 2019

Ultimo aggiornamento inviato che soddisfa i criteri QC

2 ottobre 2019

Ultimo verificato

1 ottobre 2019

Maggiori informazioni

Termini relativi a questo studio

Termini MeSH pertinenti aggiuntivi

Altri numeri di identificazione dello studio

  • SG-STEP

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

Descrizione del piano IPD

Investigators will not be storing or sharing any personal identifiers. All individual level data will be anonymized, and only anonymized data will be shared with other researchers, upon request.

Periodo di condivisione IPD

After completion of all analysis. It will be made available in the supporting documentation.

Criteri di accesso alla condivisione IPD

It will be made available in the supporting documentation.

Tipo di informazioni di supporto alla condivisione IPD

  • STUDIO_PROTOCOLLO
  • ICF
  • CODICE_ANALITICO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi